Schnitzer TJ, et al. Efficacy and Safety of Subcutaneous Tanezumab for the Treatment of Osteoarthritis of the Hip or Knee. ACR 2018, abstract L20.
Promotie: Factoren die de respons op TNF-remmers beïnvloeden
jun 2021 | Arthritis psoriatica, RA
nov 2022 | Psoriasis
nov 2020
okt 2020
aug 2020 | RA, SLE